<DOC>
	<DOCNO>NCT00858598</DOCNO>
	<brief_summary>This study design observe outcome Pro Osteon accord cleared indication use .</brief_summary>
	<brief_title>Pro Osteon Bone Void Filler Study</brief_title>
	<detailed_description>The purpose prospective clinical data-collection document performance clinical outcome Pro Osteon® Bone Void Filler . FDA clear device via premarket notification 510 ( k ) K063346 , K980817 , K990131 . There experimental investigational device use .</detailed_description>
	<mesh_term>Osteoarthritis</mesh_term>
	<criteria>Inclusion criterion state indication state summary FDA approve 510 ( k ) K063346 , K980817 , K990131 application . These indication state : PRO OSTEON® 500R Resorbable Bone Graft Substitute indicate bony void gap intrinsic stability bony structure . PRO OSTEON® 500R indicate gently pack bony void gap skeletal system ( i.e , extremity , spine pelvis ) . These defect may surgically create osseous defect osseous defect create traumatic injury bone . PRO OSTEON® 500R combine autogenous blood , and/or sterile fluid ( saline Ringer 's solution ) . The product provide bone void filler resorbs replace bone heal process . Surgical technique patient care standard surgeon participate protocol maintain throughout course datacollection . All patient must sign IRBapproved Informed Consent enrol study . Exclusion criterion state contraindication state summary FDA approve 510 ( k ) K063346 , K980817 , K990131 application . These contraindication state : Pro Osteon® 500R Resorbable Bone Graft Substitute contraindicate fracture growth plate For segmental defect For indication may subject excessive impact stress When significant vascular impairment proximal graft site When metabolic systemic bone disorder affect bone wound healing In infected site When stabilization defect possible . The use Pro Osteon® 500R also contraindicate case intraoperative soft tissue coverage plan possible .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2012</verification_date>
	<keyword>Total Knee Arthroplasty</keyword>
	<keyword>Revision</keyword>
	<keyword>Tibial</keyword>
	<keyword>Void</keyword>
	<keyword>Bone Filler</keyword>
</DOC>